(Q44269685)

1 December 2017

title

AAV-based shRNA silencing of NF-κB ameliorates muscle pathologies in mdx mice (English)

1 reference

1 December 2017

0 references

Q Yang

1

1 reference

1 December 2017

Y Tang

2

1 reference

1 December 2017

K Imbrogno

3

1 reference

1 December 2017

A Lu

4

1 reference

1 December 2017

J D Proto

5

1 reference

1 December 2017

A Chen

6

1 reference

1 December 2017

F Guo

7

1 reference

1 December 2017

F H Fu

8

1 reference

1 December 2017

J Huard

9

1 reference

1 December 2017

B Wang

10

1 reference

1 December 2017

publication date

26 January 2012

1 reference

1 December 2017

1 reference

1 December 2017

volume

19

1 reference

1 December 2017

issue

12

1 reference

1 December 2017

page(s)

1196-1204

1 reference

https://scigraph.springernature.com/pub.10.1038/gt.2011.207

1 December 2017

exact match

0 references

cites work

Conservation of the Duchenne muscular dystrophy gene in mice and humans

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.207

The dystrophin glycoprotein complex: signaling strength and integrity for the sarcolemma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.207

Duchenne muscular dystrophy: deficiency of dystrophin at the muscle cell surface

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.207

The complete sequence of dystrophin predicts a rod-shaped cytoskeletal protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.207

Focusing on fibrosis: halofuginone-induced functional improvement in the mdx mouse model of Duchenne muscular dystrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.207

Interplay of IKK/NF-kappaB signaling in macrophages and myofibers promotes muscle degeneration in Duchenne muscular dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.207

Nuclear factor kappa-B blockade reduces skeletal muscle degeneration and enhances muscle function in Mdx mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.207

Tumor necrosis factor-regulated biphasic activation of NF-kappa B is required for cytokine-induced loss of skeletal muscle gene products

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.207

Mechanical stress activates the nuclear factor-kappaB pathway in skeletal muscle fibers: a possible role in Duchenne muscular dystrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.207

Pathophysiology of limb girdle muscular dystrophy type 2A: hypothesis and new insights into the IkappaBalpha/NF-kappaB survival pathway in skeletal muscle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.207

The use of recombinant adeno-associated virus for skeletal gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.207

New vectors and strategies for cardiovascular gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.207

Adeno-associated virus vector carrying human minidystrophin genes effectively ameliorates muscular dystrophy in mdx mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.207

Adeno-associated virus vector-mediated minidystrophin gene therapy improves dystrophic muscle contractile function in mdx mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.207

rAAV6-microdystrophin preserves muscle function and extends lifespan in severely dystrophic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.207

Widespread muscle expression of an AAV9 human mini-dystrophin vector after intravenous injection in neonatal dystrophin-deficient dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.207

AAV-directed muscular dystrophy gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.207

Targeted ablation of IKK2 improves skeletal muscle strength, maintains mass, and promotes regeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.207

Inhibition of the IKK/NF-κB pathway by AAV gene transfer improves muscle regeneration in older mdx mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.207

Construction and analysis of compact muscle-specific promoters for AAV vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.207

Absence of the transcription factor CCAAT enhancer binding protein alpha results in loss of myeloid identity in bcr/abl-induced malignancy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.207

Immune evasion by muscle-specific gene expression in dystrophic muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.207

Dystrophin immunity in Duchenne's muscular dystrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.207

NF-kappaB as a potential therapeutic target in osteoarthritis and rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.207

NF-kappaB regulation in the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.207

The role of p65 NF-kappaB/RelA in pancreatitis-induced Kupffer cell apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.207

A chronic inflammatory response dominates the skeletal muscle molecular signature in dystrophin-deficient mdx mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.207

Visualization of dystrophic muscle fibers in mdx mouse by vital staining with Evans blue: evidence of apoptosis in dystrophin-deficient muscle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.207

Dystrophin immunocytochemistry in muscle culture: detection of a carrier of Duchenne muscular dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.207

7 January 2021

Interaction of dystrophin with cytoskeletal proteins: binding to talin and actin

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.207

7 January 2021

Sustained AAV-mediated dystrophin expression in a canine model of Duchenne muscular dystrophy with a brief course of immunosuppression

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.207

7 January 2021

The muscular dystrophies

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.207

7 January 2021

Identifiers

DOI

10.1038/GT.2011.207

1 reference

Dimensions Publication ID

1 December 2017

1020532967

0 references

1 reference